ArticleJAMIA open2026
Key stakeholder perspectives on HA Go implementation: a Consolidated Framework for Implementation Research-informed study of a mobile health navigation tool.
Article in JAMIA open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The Hospital Authority in Hong Kong developed an application, known as 'HA Go', to enhance patients' healthcare journeys and optimize the efficiency of healthcare resource allocation. This study aimed to explore the perceptions of HA Go among the key stakeholders and identify barriers and facilitators to its adoption. Materials and Methods: This qualitative study evaluated the perceptions of six groups of key stakeholders associated with HA Go in Hong Kong including (1) users; (2) non-users; (3) caregivers; (4) physicians in the public healthcare sector; (5) physicians in the private healthcare sector; and (6) policymakers related to HA Go development. The Consolidated Framework for Implementation Research (CFIR) was adopted to guide the interview and data analysis in this study. Results: A total of 33 participants were included in this study. Among users, non-users, and caregivers, the key benefits of HA Go and facilitators included appointment management, simplification of the healthcare process, and accessible HA Go-related information and support. Among physicians and policymakers, the key benefits and facilitators included improved appointment coordination, smoother healthcare processes, and support for medication management. Across stakeholder groups, barriers included limited familiarity with digital devices, interface complexity, privacy concerns, and insufficient promotion or practical support. Discussion: Stakeholders generally perceived HA Go as useful for improving healthcare navigation and resource efficiency, while highlighting the need to address usability barriers and strengthen support for diverse user groups. Conclusions: This study highlighted the potential role of HA Go in enhancing patients' healthcare journeys and optimizing healthcare resource allocation, and identified the enablers, barriers, and opportunities for improvement. Targeted improvements in user interface design, platform integration, communication strategies, and training may support wider adoption and engagement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.